|
UroVysion® and Bladder Cancer |
|
MPLN performs the UroVysion® by FISH test to aid in the initial diagnosis of bladder cancer. The test is also used for early detection of tumor recurrence in patients previously diagnosed with bladder cancer. The non-invasive assay is performed on urine specimens from individuals with hematuria or atypical cell morphology suspected to have bladder cancer, or from patients previously diagnosed with bladder cancer.
 Test Information and Specimen Requirements
For more information about the UroVysion test, contact one of our service specialists at 800-932-2943.
Our Testing Resources
 UroVysion® and bladder cancer information
|
